000132854 001__ 132854
000132854 005__ 20240229105035.0
000132854 0247_ $$2doi$$a10.1016/j.jocn.2018.01.048
000132854 0247_ $$2pmid$$apmid:29402569
000132854 0247_ $$2ISSN$$a0967-5868
000132854 0247_ $$2ISSN$$a1532-2653
000132854 037__ $$aDKFZ-2018-00497
000132854 041__ $$aeng
000132854 082__ $$a610
000132854 1001_ $$aRogers, Sasha$$b0
000132854 245__ $$aUnusual paediatric spinal myxopapillary ependymomas: Unique molecular entities or pathological variations on a theme?
000132854 260__ $$aBurlington, Mass.$$bHarcourt$$c2018
000132854 3367_ $$2DRIVER$$aarticle
000132854 3367_ $$2DataCite$$aOutput Types/Journal article
000132854 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1525867425_15505
000132854 3367_ $$2BibTeX$$aARTICLE
000132854 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000132854 3367_ $$00$$2EndNote$$aJournal Article
000132854 520__ $$aEpendymomas are the commonest type of spinal glioma which represent a group of relatively benign tumours. Myxopapillary ependymoma (MPE) is a common variant found within the distal spinal cord around the conus. These two entities are clearly differentiated on the basis of their characteristic histological and molecular features. Rare variants of MPE's are described in the literature to have the propensity to metastasise and grow in extraspinal locations despite appearing histologically identical to their more benign relatives. Here, we describe two unusual cases of MPE and utilise DNA methylation analyses to compare their molecular signatures with known molecular subtypes of ependymoma in an attempt to distinguish whether these tumours represent a unique subset of disease.
000132854 536__ $$0G:(DE-HGF)POF3-312$$a312 - Functional and structural genomics (POF3-312)$$cPOF3-312$$fPOF III$$x0
000132854 588__ $$aDataset connected to CrossRef, PubMed,
000132854 7001_ $$0P:(DE-He78)551bb92841f634070997aa168d818492$$aJones, David$$b1$$udkfz
000132854 7001_ $$aIreland, Amanda$$b2
000132854 7001_ $$aGottardo, Nick G$$b3
000132854 7001_ $$aEndersby, Raelene$$b4
000132854 773__ $$0PERI:(DE-600)2009190-4$$a10.1016/j.jocn.2018.01.048$$gVol. 50, p. 144 - 148$$p144 - 148$$tJournal of clinical neuroscience$$v50$$x0967-5868$$y2018
000132854 909CO $$ooai:inrepo02.dkfz.de:132854$$pVDB
000132854 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)551bb92841f634070997aa168d818492$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000132854 9131_ $$0G:(DE-HGF)POF3-312$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunctional and structural genomics$$x0
000132854 9141_ $$y2018
000132854 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000132854 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000132854 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000132854 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ CLIN NEUROSCI : 2015
000132854 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000132854 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000132854 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000132854 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000132854 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000132854 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lPädiatrische Neuroonkologie$$x0
000132854 980__ $$ajournal
000132854 980__ $$aVDB
000132854 980__ $$aI:(DE-He78)B062-20160331
000132854 980__ $$aUNRESTRICTED